http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114107572-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-701 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-686 |
| filingDate | 2022-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114107572-B |
| titleOfInvention | Primer probe set for detecting different new coronavirus mutant strains based on multiplex PCR technology, detection kit and application of detection kit |
| abstract | The invention provides a primer probe group for detecting different new coronavirus mutant strains based on a multiple PCR technology, a detection kit and application thereof, and belongs to the technical field of virus detection. The invention downloads 14 new coronavirus mutant sequences, determines S protein mutation sites and conserved sequences of new coronaviruses with detection significance, designs multiple amplification primers, performs single-tube multiple PCR amplification, hybridizes amplification products with probes, judges whether a detected sample contains the novel coronavirus detection according to the detection result of the new coronaviruses conserved sequences, and judges the sample to be the novel coronavirus mutant according to the detection result of the S protein mutation sites. The invention has wide detection range, strong specificity, high detection sensitivity and strong anti-interference capability, can effectively evaluate the transmissibility and pathogenicity of SARS-CoV-2 infected by a detected person and whether the vaccine has immune escape, and is also beneficial to analyzing and researching the variation rule of SARS-CoV-2 and inspiring new ideas of controlling the circulation and preventing the reoccurrence. |
| priorityDate | 2022-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 236.